West Pharmaceutical Services Other Current Assets 2010-2024 | WST

West Pharmaceutical Services other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • West Pharmaceutical Services other current assets for the quarter ending June 30, 2024 were $0.138B, a 46.87% increase year-over-year.
  • West Pharmaceutical Services other current assets for 2023 were $0.136B, a 31.84% increase from 2022.
  • West Pharmaceutical Services other current assets for 2022 were $0.103B, a 8.04% decline from 2021.
  • West Pharmaceutical Services other current assets for 2021 were $0.112B, a 117.05% increase from 2020.
West Pharmaceutical Services Annual Other Current Assets
(Millions of US $)
2023 $136
2022 $103
2021 $112
2020 $52
2019 $65
2018 $54
2017 $39
2016 $39
2015 $37
2014 $36
2013 $42
2012 $38
2011 $47
2010 $43
2009 $38
West Pharmaceutical Services Quarterly Other Current Assets
(Millions of US $)
2024-06-30 $138
2024-03-31 $137
2023-12-31 $136
2023-09-30 $123
2023-06-30 $94
2023-03-31 $91
2022-12-31 $103
2022-09-30 $106
2022-06-30 $113
2022-03-31 $108
2021-12-31 $112
2021-09-30 $80
2021-06-30 $75
2021-03-31 $67
2020-12-31 $52
2020-09-30 $51
2020-06-30 $49
2020-03-31 $58
2019-12-31 $65
2019-09-30 $62
2019-06-30 $55
2019-03-31 $58
2018-12-31 $54
2018-09-30 $43
2018-06-30 $37
2018-03-31 $38
2017-12-31 $39
2017-09-30 $40
2017-06-30 $38
2017-03-31 $46
2016-12-31 $39
2016-09-30 $42
2016-06-30 $40
2016-03-31 $49
2015-12-31 $37
2015-09-30 $34
2015-06-30 $34
2015-03-31 $36
2014-12-31 $36
2014-09-30 $33
2014-06-30 $44
2014-03-31 $44
2013-12-31 $42
2013-09-30 $30
2013-06-30 $34
2013-03-31 $35
2012-12-31 $38
2012-09-30 $36
2012-06-30 $33
2012-03-31 $35
2011-12-31 $47
2011-09-30 $65
2011-06-30 $62
2011-03-31 $57
2010-12-31 $43
2010-09-30 $45
2010-06-30 $40
2010-03-31 $40
2009-12-31 $38
2009-09-30 $37
2009-06-30 $32
2009-03-31 $30
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.575B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.818B 18.37
McKesson (MCK) United States $65.897B 18.13
Cardinal Health (CAH) United States $26.800B 14.83
Cooper (COO) United States $22.126B 31.50
Align Technology (ALGN) United States $19.210B 37.11
Labcorp (LH) United States $18.857B 15.71
Henry Schein (HSIC) United States $9.191B 16.83
Merit Medical Systems (MMSI) United States $5.834B 30.84
DENTSPLY SIRONA (XRAY) United States $5.453B 14.62
CONMED (CNMD) United States $2.323B 20.20
Patterson (PDCO) United States $1.962B 10.35
STAAR Surgical (STAA) United States $1.554B 70.22
Lifevantage (LFVN) United States $0.129B 17.76
Pro-Dex (PDEX) United States $0.093B 44.55